Catherine Isted, a chartered accountant and finance professional, has been appointed chief financial officer of ReNeuron Group Plc, the UK-based cell therapy company. Her appointment is effective on 11 October. Ms Isted will join from Oxford Biomedica Plc where she headed up corporate development and investor relations. She has also held research analyst and equity sales positions in the healthcare teams at Morgan Stanley, ABN AMRO, Nomura and Peel Hunt.
Ms Isted holds a degree in chemistry from the University of Leicester, UK.
ReNeuron announced the appointment on 6 August 2021.
Copyright 2021 Evernow Publishing Ltd